1 / 8

New Report Projects Growth of Continuous Glucose Monitoring Systems Market

Continuous Glucose Monitoring Systems Market study provides an in-depth analysis of the global continuous glucose monitoring systems market, with current trends and future estimations to elucidate the imminent investment pockets. Quantitative analysis from 2016 to 2024 is expected to enable the stakeholders to capitalize on prevailing market opportunities.<br><br>

srushtih123
Download Presentation

New Report Projects Growth of Continuous Glucose Monitoring Systems Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Continuous Glucose Monitoring Systems Market is the Next Frontier for Healthcare Industry Global Opportunity Analysis and Industry Forecast, 2016-2024

  2. Continuous Glucose Monitoring Systems Market “CGMS are a more efficient monitoring and treatment alternative for patients with diabetes. Thus, FDA approval for the novel and innovative products such as artificial pancreas (dual-chambered investigational device that consists of a CGM, one insulin pump, and a control algorithm) would further drive the CGMS market.”

  3. Continuous Glucose Monitoring Systems Market Overview Continuous Glucose Monitoring Systems (CGMS) Market by Components, Demographics, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024. Access Full Summary at : https://www.alliedmarketresearch.com/global-continuous-glucose-monitoring-systems-market The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors drive the growth of the CGMS market. Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions.  

  4. Continuous Glucose Monitoring Systems Market According to the International Diabetes Federation, the number of diabetic population is expected to reach 642 million by the year 2040 as compared to 415 million patients in 2015, worldwide. Thus, one out of every ten adults is expected to have diabetes by 2040, which reveals the graveness of this pandemic. Therefore, the treatment, and management of diabetes is expected to be the prime focus areas of healthcare departments and stakeholders, globally. The increase in incidence of diabetic cases would provide high market growth and opportunities, which in turn will attract and compel numerous market players to develop innovative products or product line extensions. The aforementioned factors are expected to boost the overall growth of the market. The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. 

  5. Continuous Glucose Monitoring Systems Market, Snapshot It is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years. On the basis of demographics, CGMS devices are categorized into child population (≤14 years) and adult population (>14 years). The report includes comprehensive geographical analysis and segmentation of geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA.  The key companies operating in the market include Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

  6. Key Findings of Continuous Glucose Monitoring Systems Market • The sensors segment contributed for nearly two-third share of the global continuous glucose monitoring systems market in 2016. • The integrated insulin pumps segment is projected to grow at a significant CAGR of 17.3% from 2018 to 2023. • The ICUs segment is projected to grow at a significant CAGR of 22.3% during the forecast period. • Germany and France are the major shareholders, which collectively accounted for more than one-fourth share of the European continuous glucose monitoring systems market in 2016. • Japan is the major shareholder, accounting for more than one-fourth share of the Asia-Pacific continuous glucose monitoring systems market in 2016. 

  7. Continuous Glucose Monitoring Systems Market North America Europe Asia-Pacific LAMEA

  8. Continuous Glucose Monitoring Systems Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/1795 Follow Us On

More Related